Erratum: Clinical and biological significance of <i>de novo</i> CD5+ diffuse large B-cell lymphoma in Western countries

Zijun Y. Xu‐Monette(Duke University), Ken H. Young(Duke Medical Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Maurilio Ponzoni(San Raffaele University of Rome), Yuji An(The University of Texas MD Anderson Cancer Center), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Xin Cao(Beijing Tsinghua Chang Gung Hospital), Kristy L. Richards(University of North Carolina at Chapel Hill), April Chiu(Mayo Clinic), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Youli Zu(Methodist Hospital), Qinging Cai(The University of Texas MD Anderson Cancer Center), John P. Farnen(Gundersen Health System), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Jooryung Huh(Asan Medical Center), Xiaoying Zhao(Handan College), William W.L. Choi(Chinese University of Hong Kong), Meifeng Tu(Peking University), Lalitha Nagarajan(The University of Texas MD Anderson Cancer Center), L. Jeffrey Medeiros(Delaware Division of Libraries), Kausar J. Jabbar(Beaumont Health), Jane N. Winter(Northwestern University)
Oncotarget
March 8, 2015
Cited by 3


Related Papers